Detalhe da pesquisa
1.
Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.
Acta Anaesthesiol Scand
; 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38549422
2.
Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.
Acta Anaesthesiol Scand
; 68(2): 146-166, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37881881
3.
Empirical meropenem versus piperacillin/tazobactam for adult patients with sepsis (EMPRESS) trial: Protocol.
Acta Anaesthesiol Scand
; 2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38769040
4.
Use of days alive without life support and similar count outcomes in randomised clinical trials - an overview and comparison of methodological choices and analysis methods.
BMC Med Res Methodol
; 23(1): 139, 2023 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37316785
5.
Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia-Post hoc exploratory analyses of the COVID STEROID 2 trial.
Acta Anaesthesiol Scand
; 67(2): 195-205, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36314057
6.
Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: A systematic review with meta-analysis.
Acta Anaesthesiol Scand
; 67(7): 853-868, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36919866
7.
Association between days alive without life support/out of hospital and health-related quality of life.
Acta Anaesthesiol Scand
; 67(6): 762-771, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36915265
8.
Health-related quality of life and days alive without life support or out of hospital: Protocol.
Acta Anaesthesiol Scand
; 66(2): 295-301, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34811741
9.
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.
Acta Anaesthesiol Scand
; 65(5): 702-710, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33583027
10.
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial.
Acta Anaesthesiol Scand
; 65(10): 1421-1430, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34138478
11.
Peer instruction versus conventional group work-based teaching in a laboratory exercise on respiratory physiology: a randomized study.
Adv Physiol Educ
; 45(4): 694-701, 2021 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34498941
12.
Long-term mortality and health-related quality of life in the COVID STEROID trial.
Acta Anaesthesiol Scand
; 66(4): 543-545, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35067914
13.
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.
Lancet Reg Health Southeast Asia
; 20: 100293, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38234702
14.
Causal Bayesian machine learning to assess treatment effect heterogeneity by dexamethasone dose for patients with COVID-19 and severe hypoxemia.
Sci Rep
; 13(1): 6570, 2023 04 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37085591
15.
Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial.
Ann Intensive Care
; 13(1): 12, 2023 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36862239
16.
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.
Intensive Care Med
; 48(1): 45-55, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34757439
17.
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
Intensive Care Med
; 48(5): 580-589, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35359168
18.
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis.
Intensive Care Med
; 47(5): 521-537, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33876268
19.
Choice of priors: how much scepticism is appropriate?
Intensive Care Med
; 48(3): 372-373, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35024884
20.
Time for tocilizumab in COVID-19?
Intensive Care Med
; 47(6): 692-694, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34057560